Appropriate Chemotherapy Dosing For Obese Adult Patients With Cancer

Publication Date: April 2, 2012
Last Updated: March 14, 2022


The Panel recommends that actual body weight be used when selecting cytotoxic chemotherapy doses regardless of obesity status. There is no evidence that short- or long-term toxicity is increased among obese patients receiving full weight–based chemotherapy doses. Most data indicate that myelosuppression is the same or less pronounced among the obese than the non-obese when administered full weight–based doses.



Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer

Authoring Organization